279 related articles for article (PubMed ID: 9121430)
1. Tyrosine phosphorylation sites at amino acids 239 and 240 of Shc are involved in epidermal growth factor-induced mitogenic signaling that is distinct from Ras/mitogen-activated protein kinase activation.
Gotoh N; Toyoda M; Shibuya M
Mol Cell Biol; 1997 Apr; 17(4):1824-31. PubMed ID: 9121430
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine residues 239 and 240 of Shc are phosphatidylinositol 4,5-bisphosphate-dependent phosphorylation sites by c-Src.
Sato K; Gotoh N; Otsuki T; Kakumoto M; Aoto M; Tokmakov AA; Shibuya M; Fukami Y
Biochem Biophys Res Commun; 1997 Nov; 240(2):399-404. PubMed ID: 9388490
[TBL] [Abstract][Full Text] [Related]
3. The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein-protein interactions.
van der Geer P; Wiley S; Gish GD; Pawson T
Curr Biol; 1996 Nov; 6(11):1435-44. PubMed ID: 8939605
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor-receptor mutant lacking the autophosphorylation sites induces phosphorylation of Shc protein and Shc-Grb2/ASH association and retains mitogenic activity.
Gotoh N; Tojo A; Muroya K; Hashimoto Y; Hattori S; Nakamura S; Takenawa T; Yazaki Y; Shibuya M
Proc Natl Acad Sci U S A; 1994 Jan; 91(1):167-71. PubMed ID: 7506413
[TBL] [Abstract][Full Text] [Related]
5. Relative involvement of Shc tyrosine 239/240 and tyrosine 317 on insulin induced mitogenic signaling in rat1 fibroblasts expressing insulin receptors.
Ishihara H; Sasaoka T; Wada T; Ishiki M; Haruta T; Usui I; Iwata M; Takano A; Uno T; Ueno E; Kobayashi M
Biochem Biophys Res Commun; 1998 Nov; 252(1):139-44. PubMed ID: 9813159
[TBL] [Abstract][Full Text] [Related]
6. Roles of Lck, Syk and ZAP-70 tyrosine kinases in TCR-mediated phosphorylation of the adapter protein Shc.
Walk SF; March ME; Ravichandran KS
Eur J Immunol; 1998 Aug; 28(8):2265-75. PubMed ID: 9710204
[TBL] [Abstract][Full Text] [Related]
7. Functional importance of amino-terminal domain of Shc for interaction with insulin and epidermal growth factor receptors in phosphorylation-independent manner.
Sasaoka T; Ishihara H; Sawa T; Ishiki M; Morioka H; Imamura T; Usui I; Takata Y; Kobayashi M
J Biol Chem; 1996 Aug; 271(33):20082-7. PubMed ID: 8702728
[TBL] [Abstract][Full Text] [Related]
8. A novel pathway from phosphorylation of tyrosine residues 239/240 of Shc, contributing to suppress apoptosis by IL-3.
Gotoh N; Tojo A; Shibuya M
EMBO J; 1996 Nov; 15(22):6197-204. PubMed ID: 8947042
[TBL] [Abstract][Full Text] [Related]
9. Potent SHC tyrosine phosphorylation by epidermal growth factor at low receptor density or in the absence of receptor autophosphorylation sites.
Soler C; Alvarez CV; Beguinot L; Carpenter G
Oncogene; 1994 Aug; 9(8):2207-15. PubMed ID: 8036006
[TBL] [Abstract][Full Text] [Related]
10. Activation of the Ras/mitogen-activated protein kinase pathway by kinase-defective epidermal growth factor receptors results in cell survival but not proliferation.
Walker F; Kato A; Gonez LJ; Hibbs ML; Pouliot N; Levitzki A; Burgess AW
Mol Cell Biol; 1998 Dec; 18(12):7192-204. PubMed ID: 9819406
[TBL] [Abstract][Full Text] [Related]
11. Modulation of insulin-like growth factor I mitogenic signaling in 3T3-L1 preadipocyte differentiation.
Boney CM; Smith RM; Gruppuso PA
Endocrinology; 1998 Apr; 139(4):1638-44. PubMed ID: 9528944
[TBL] [Abstract][Full Text] [Related]
12. Controlling epidermal growth factor (EGF)-stimulated Ras activation in intact cells by a cell-permeable peptide mimicking phosphorylated EGF receptor.
Rojas M; Yao S; Lin YZ
J Biol Chem; 1996 Nov; 271(44):27456-61. PubMed ID: 8910327
[TBL] [Abstract][Full Text] [Related]
13. Prolactin inhibits epidermal growth factor-induced Ras-MAPK signaling in mammary epithelial cells.
Johnson JL; Fenton S; Sheffield LG
J Biol Chem; 1996 Aug; 271(35):21574-8. PubMed ID: 8702944
[TBL] [Abstract][Full Text] [Related]
14. N-Shc: a neural-specific adapter molecule that mediates signaling from neurotrophin/Trk to Ras/MAPK pathway.
Nakamura T; Sanokawa R; Sasaki Y; Ayusawa D; Oishi M; Mori N
Oncogene; 1996 Sep; 13(6):1111-21. PubMed ID: 8808684
[TBL] [Abstract][Full Text] [Related]
15. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells.
Sakaguchi K; Okabayashi Y; Kido Y; Kimura S; Matsumura Y; Inushima K; Kasuga M
Mol Endocrinol; 1998 Apr; 12(4):536-43. PubMed ID: 9544989
[TBL] [Abstract][Full Text] [Related]
16. Protein phosphatase 2A forms a molecular complex with Shc and regulates Shc tyrosine phosphorylation and downstream mitogenic signaling.
Ugi S; Imamura T; Ricketts W; Olefsky JM
Mol Cell Biol; 2002 Apr; 22(7):2375-87. PubMed ID: 11884620
[TBL] [Abstract][Full Text] [Related]
17. Gbetagamma subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation.
Luttrell LM; Della Rocca GJ; van Biesen T; Luttrell DK; Lefkowitz RJ
J Biol Chem; 1997 Feb; 272(7):4637-44. PubMed ID: 9020193
[TBL] [Abstract][Full Text] [Related]
18. Mutation of a Shc binding site tyrosine residue in ErbB3/HER3 blocks heregulin-dependent activation of mitogen-activated protein kinase.
Vijapurkar U; Cheng K; Koland JG
J Biol Chem; 1998 Aug; 273(33):20996-1002. PubMed ID: 9694850
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of SHIP-mediated inhibition of insulin- and platelet-derived growth factor-stimulated mitogen-activated protein kinase activity in 3T3-L1 adipocytes.
Sharma PM; Son HS; Ugi S; Ricketts W; Olefsky JM
Mol Endocrinol; 2005 Feb; 19(2):421-30. PubMed ID: 15486046
[TBL] [Abstract][Full Text] [Related]
20. Pertussis toxin-sensitive and insensitive intracellular signalling pathways in undifferentiated 3T3-L1 cells stimulated by insulin converge with phosphatidylinositol 3-kinase upstream of the Ras mitogen-activated protein kinase cascade.
Uehara T; Tokumitsu Y; Nomura Y
Eur J Biochem; 1999 Feb; 259(3):801-8. PubMed ID: 10092867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
